-transparent.png){kind=logo}
Gingival hyperplasia, a condition characterized by increased amounts of gingival connective tissue, has most commonly been observed in patients receiving phenytoin, but has also been noted in patients receiving cyclosporine and, as in this case report, nifedipine. Patients receiving nifedipine should be advised to practice good oral hygiene to lessen the possibility of hyperplasia occurring. If gingival hyperplasia develops in a patient taking nifedipine, the drug should be suspected as being responsible and discontinued. Limited data suggest verapamil can be substituted for nifedipine in these patients with improvement of the hyperplasia.
Related Publications
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
January 1992,
Annals of dentistry,
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
April 1992,
The Journal of the Tennessee Dental Association,
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
March 1996,
American family physician,
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
January 1991,
Revista europea de odonto-estomatologia,
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
May 1989,
Journal (Canadian Dental Association),
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
December 1992,
Dental update,
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
January 1988,
Duodecim; laaketieteellinen aikakauskirja,
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
October 1987,
Medicina clinica,
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
June 1991,
The Journal of the Association of Physicians of India,
A A Shaftic, and
L L Widdup, and
M A Abate, and
A I Jacknowitz
March 1988,
The Journal of the Association of Physicians of India,
